BCYC analyst estimates
Bicycle Therapeutics (BCYC) analyst ratings, the average price target and its range, and every firm's latest call.
- 5 firms rate BCYC: 3 buy, 2 hold, 0 sell.
- The average price target is $10.00 from None analysts, from $10.00 to $10.00.
BCYC analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 29, 2026 | Jefferies | Bicycle Therapeutics (BCYC) PT Lowered to $10 at Jefferies | $10.00 |
| Apr 30, 2026 | Jefferies | Bicycle Therapeutics price target lowered to $12 from $13 at Jefferies | $12.00 |
| Apr 8, 2026 | Morgan Stanley | Bicycle Therapeutics price target lowered to $12 from $13 at Morgan Stanley | $12.00 |
| Mar 17, 2026 | Morgan Stanley | Morgan Stanley on Bicycle Therapeutics (BCYC): program deprioritization 'disappointing,' but 'right call' | $13.00 |
| Mar 17, 2026 | Truist Financial | Bicycle Therapeutics (BCYC) PT Lowered to $8 at Truist Securities | $8.00 |
| Nov 24, 2025 | Truist Financial | Bicycle Therapeutics initiated with a Hold at Truist | $10.00 |
| Oct 31, 2025 | RBC Capital | RBC downgrades Bicycle Therapeutics on slow pipeline progress | $11.00 |
| Oct 31, 2025 | JMP Securities | Bicycle Therapeutics price target raised to $12 from $10 at Citizens JMP | $12.00 |
| Aug 11, 2025 | RBC Capital | Bicycle Therapeutics price target raised to $27 from $25 at RBC Capital | $27.00 |
| May 5, 2025 | Morgan Stanley | Bicycle Therapeutics price target raised to $17 from $15 at Morgan Stanley | $17.00 |
| Dec 18, 2024 | JMP Securities | Bicycle Therapeutics price target lowered to $26 from $32 at JMP Securities | $26.00 |
| Oct 24, 2024 | B.Riley Financial | B.Riley Reiterates Neutral Rating on Bicycle Therapeutics (BCYC) | $28.00 |
| Oct 24, 2024 | Oppenheimer | Oppenheimer Reiterates Outperform Rating on Bicycle Therapeutics (BCYC) | $48.00 |
| Sep 16, 2024 | H.C. Wainwright | H.C. Wainwright Reiterates Buy Rating on Bicycle Therapeutics (BCYC) | $55.00 |
| Oct 7, 2021 | Piper Sandler | Bicycle Therapeutics price target raised to $76 from $46 at Piper Sandler | $76.00 |